HUMANIGEN, INC.
HGEN
HGEN was delisted on the 25th of July, 2023.
3 hedge funds and large institutions have $509 invested in HUMANIGEN, INC. in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 35 closing their positions.
92% less funds holding
Funds holding: 38 → 3 (-35)
100% less capital invested
Capital invested by funds: $841K → $509 (-$840K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 35
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$261K |
| 2 |
Bank of New York Mellon
New York
|
-$134K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$131K |
| 4 |
BlackRock
New York
|
-$124K |
| 5 |
State Street
Boston,
Massachusetts
|
-$28.8K |
HGEN Hedge Fund Activity: Q3 2023 in Review
3 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in HUMANIGEN, INC. (HGEN) for Q3 2023, worth a combined $509 — down 100% from $841K a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of HGEN and 0 opened new positions — a net loss of 35 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Vanguard Group, exiting entirely with an estimated $261K sold.
- 3 institutional investors held HUMANIGEN, INC. (HGEN) as of Q3 2023, down from 38 in Q2 2023.
- Funds reported $509 of HUMANIGEN, INC. stock for Q3 2023, down 100% quarter-over-quarter.
- 0 funds opened new HUMANIGEN, INC. positions in Q3 2023 and 35 closed out, a net change of -35 holders.
- The largest HUMANIGEN, INC. seller in Q3 2023 was Vanguard Group, an estimated $261K sold.
Based on aggregated 13F filings for Q3 2023.